ArticleAmerican journal of cancer research2022

A novel risk model based on immune response predicts clinical outcomes and characterizes immunophenotypes in triple-negative breast cancer.

Xunxi Lu et al.PubMed ↗Full text ↗

No numbers read from the abstract.